Bureau Veritas is a world leader in Testing, Inspection and Certification. Our mission is at the heart of key challenges: quality, health and safety, environmental protection and social responsibility. Through our wide range of expertise, impartiality and independence, we foster confidence between companies, public authorities and clients.
Bureau Veritas is a Business to Business to Society company, contributing to transform the world we live in. Driven by society, we are working ever more closely with our clients, addressing today’s crucial challenges and answering society’s aspirations.
Bureau Veritas is listed on the Euronext Paris (Compartment A, code ISIN FR 0006174348, stock symbol: BVI).
Healthscope is a leading private healthcare provider with 38 hospitals across Australia.
We strive to be the best place to work and care in Australian healthcare.
Our team of over 19,000 employees make an impact 24/7, 365 days a year by providing exceptional care to the more than 650,000 Australians we see each year.
Nucleus Network is the only global provider dedicated to early phase clinical trials, with units in Australia, the USA and the UK. Our unified network provides sponsors access to all three major regulatory markets through one trusted partner.
With more than 2,500 early phase studies and 1,500 First in Human trials over 30 years, we are the most experienced early phase team worldwide. We are recognised for managing complex and adaptive designs with confidence, supported by proven scientific leadership and operational delivery. Alongside First in Human expertise, we conduct the full spectrum of clinical pharmacology studies, giving sponsors the depth, consistency and participant access to accelerate new medicines.
One Network. Multiple Pathways.
The Power of a Unified Global Network.